On March 3, 2026, Beijing Cotecna Kaixin Certification Co., Ltd. (hereinafter referred to as "Cotecna Kaixin") successfully passed the annual review by the EXCiPACT Office, marking that the company's professional capabilities and compliance levels in the field of GMP/GDP certification services for pharmaceutical excipients have once again been recognized by international authorities.

From January 8 to 9, 2026, assessors from the China National Accreditation Service for Conformity Assessment (CNAS) conducted an on-site witness assessment of the ISO 22000 and HACCP system audit performed by the Cotecna Kaixin audit team at Aibeicheng Pharmaceutical Technology (Shandong) Co., Ltd.

On December 10, 2025, Beijing Cotecna Kaixin Certification Co., Ltd. (hereinafter referred to as “Cotecna Kaixin”), formerly known as Kaixin Certification (Beijing) Co., Ltd., jointly convened the 2025 Annual Meeting with EXCiPACT, the internationally recognized authority for pharmaceutical excipient certification.

In December 2025, Beijing Cotecna Kaixin Certification Co., Ltd. (hereinafter referred to as “Cotecna Kaixin”), formerly known as Kaixin Certification (Beijing) Co., Ltd., successfully passed the 2025 ANAB Annual Office Assessment conducted by the ANSI National Accreditation Board (ANAB). With its robust management systems and professional service capabilities, Cotecna Kaixin continues to receive international authoritative recognition.